Zimmer Biomet
-
Financial
Zimmer Biomet Announces Third Quarter 2022 Financial Results
Third quarter net sales from continuing operations of $1.670 billion decreased 0.9% and increased 5.0% on a constant currency1 basisThird quarter diluted earnings…
Read More » -
Regulatory
Zimmer Biomet Receives FDA Clearance for Identity™ Shoulder System for Shoulder Replacement
WARSAW, Ind., Sept. 20, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Recon
Zimmer Biomet and Surgical Planning Associates Announce Exclusive Multi-Year Co-Marketing Agreement for HipInsight™ Mixed Reality System for Total Hip Replacement
WARSAW, Ind., Sept. 1, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2022
WARSAW, Ind., Aug. 26, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Robotics
Zimmer Biomet and Hospital for Special Surgery (HSS) Announce Creation of the HSS/Zimmer Biomet Innovation Center for Artificial Intelligence in Robotic Joint Replacement
First-of-its-kind multi-year collaboration established to co-develop innovative artificial intelligence-based decision support tools for robotic-assisted joint surgery WARSAW, Ind. and NEW YORK, July 28, 2022 /PRNewswire/…
Read More » -
Financial
Zimmer Biomet Announces Appointment of Keri P. Mattox as Chief Communications and Administration Officer
Expanded Role Adds Responsibility for Environmental, Social and Governance (ESG) Strategy and Office of the CEO to Portfolio WARSAW, Ind., May…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2022
WARSAW, Ind., May 17, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Financial
Zimmer Biomet Announces First Quarter 2022 Financial Results
First quarter net sales from continuing operations of $1.663 billion increased 3.9% and 6.8% on a constant currency1 basisFirst quarter diluted earnings per…
Read More » -
Recon
Zimmer Biomet Debuts WalkAI™ Artificial Intelligence Model to Predict Post-Operative Recovery Progress
WalkAI Adds Predictive Artificial Intelligence Capabilities to ZBEdge™ Connected Intelligence Suite, Offering Surgeons Data-Driven Guidance to Identify Patients with Lagging…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2022
WARSAW, Ind., Feb. 22, 2022 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that…
Read More » -
Financial
Zimmer Biomet Announces Fourth Quarter and Full-Year 2021 Financial Results
– Fourth quarter net sales of $2.038 billion decreased 2.3% and 0.8% on a constant currency[1] basis – Fourth quarter…
Read More »